Transient Ischemic Attack (TIA) and Spoken Language
Identification and Perceptions of Spoken Language Abilities After Transient Ischaemic Attack (TIA): An Exploratory, Longitudinal Study
1 other identifier
observational
30
1 country
1
Brief Summary
Transient Ischaemic Attack (also known as TIA or 'mini-stroke') affects about 46,000 people in the UK each year. It is assumed that people recover fully within 24 hours. However, subtle problems with speaking, and confidence with their communication skills can be long-term. This project will be the first in depth exploration of speaking abilities after recent TIA where there seemed to be a full recovery. The researchers will look for 90 volunteers for detailed testing. Thirty people who have had a TIA for the first time. For comparisons, the researchers will also include 60 volunteers without TIA (30 treated to prevent TIA and stroke; 30 who do not receive prevention treatments). Aims and methods:
- 1.To find out if TIA makes speaking difficult.
- 2.To find out if people are concerned about their speech and other thinking skills after TIA.
- 3.To find out if speaking abilities and people's own views of their communication change over time (about three months after the TIA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 23, 2025
CompletedStudy Start
First participant enrolled
October 1, 2025
CompletedFirst Posted
Study publicly available on registry
October 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
October 3, 2025
April 1, 2025
1.7 years
April 23, 2025
September 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Speech rate
measured as number of words per minute
From enrollment
Mean length of sentence
measured in number of words
From enrollment
Sentence complexity
measured as number of complex sentences
From enrollment
Functional Memory Questionnaire
Patient-reported measure of perceptions of memory, attention, language abilities; score range 0 to 140; higher scores mean a worse outcome
From enrollment
Communication Confidence Rating Scale for Aphasia
Patient-reported measure of confidence of communication abilities; score range 0 to 600; higher scores mean worse outcome
From enrollment
Secondary Outcomes (3)
Filled pause rate
From enrollment
Lexical richness
From enrollment
Propositional idea density
From enrollment
Eligibility Criteria
TIA group: Individuals who have had a recent single medically confirmed TIA following an in-person review at a TIA clinic. Vascular risk factor group: People aged 40-75 with vascular risk factors (e.g., hypertension, diabetes, hyperlipidemia) who receive medical treatment for these conditions and have attended a TIA clinic but were not diagnosed with a TIA. Healthy group: People aged 40-75 who have no self-reported vascular risk factors for which they take medication.
You may not qualify if:
- Younger than 40 years or older than 85 years of age.
- English as a secondary language.
- Neurological conditions affecting cognitive function (e.g., Parkinson's disease, dementia, stroke).
- Self-reported, pre-existing speech or cognitive problems, developmental or acquired.
- Demonstrate noticeable difficulties carrying out project-related tasks.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Newcastle Universitylead
- Northumbria Healthcare NHS Foundation Trustcollaborator
Study Sites (1)
Newcastle University
Newcastle upon Tyne, Tyne and Wear, NE1 7RU, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christos Salis, PhD
Newcastle University
- STUDY CHAIR
Lisa Shaw, MD
Newcastle University
- STUDY CHAIR
Christopher Price, MD
Newcastle University
- STUDY CHAIR
Mahmoud Kargar, MSc
Newcastle University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 23, 2025
First Posted
October 3, 2025
Study Start
October 1, 2025
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
June 30, 2027
Last Updated
October 3, 2025
Record last verified: 2025-04